We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitlePR-104 a bioreductive pre-prodrug combined with gemcitabine or docetaxel in a phase Ib study of patients with advanced solid tumours.AuthorsMcKeage MJ; Jameson MB; Ramanathan RK; Rajendran J; Gu Y; Wilson WR; Melink TJ; Tchekmedyian NSPublicationBMC cancer, 2012, Vol 12, p496ISSN1471-2407Publication typearticleDOI10.1186/1471-2407-12-496